YCCI News and Events
Diabetes Newsletter
The Spring 2012 Diabetes newsletter highlights the latest research to develop new treatments for type 1 and type 2 diabetes, as well as tips to help patients manage the disease.
Yale hosts national conference on translating medical research into patient care
Yale School of Medicine invites you to attend the fifth annual Clinical Research Management Workshop, where hundreds of scientists and clinicians gather to learn new tools for improving and speeding up the process of translational medicine and clinical trials. This is the first year the conference has been held outside of the Washington, D.C. area.
Rebuilding a heart, saving a life
A young girl in Bridgeport, Connecticut, born with one of the most serious, life-threatening congenital heart defects known, is on her way to living a normal life thanks to Yale doctors who developed and performed the first operation of its kind in the United States.
YCCI's Winter 2012 Newsletter is Here
The Winter 2012 edition of the YCCI newsletter is devoted to our education programs. It highlights the latest round of Junior Faculty Scholars, contains profiles of an Investigative Medicine Program and TL1 trainee, and has updates on collaborations and events.
Training parents is good medicine for children with autism behavior problems
Children with autism spectrum disorders who also have serious behavioral problems responded better to medication combined with training for their parents than to treatment with medication alone, Yale researchers and their colleagues report in the February issue of Journal of the American Academy of Child & Adolescent Psychiatry.
Secret of sperm quality control revealed by Yale scientists
Yale researchers have discovered how the "guardian of the genome'' oversees quality control in the production of sperm — and perhaps in many other cells as well.
Sweeping genetic analysis of rare disease yields common mechanism of hypertension
Analyzing all the genes of dozens of people suffering from a rare form of hypertension, Yale University researchers have discovered a new mechanism that regulates the blood pressure of all humans.
Statins may protect against death from aneurysm, Yale study finds
A study by Yale School of Medicine reveals that survival rates for patients with a thoracic aneurysm are significantly better, and complications are fewer, among patients who take statin cholesterol drugs than those who do not.
Yale asks community to help us discover cures for disease
Yale University is launching a major effort to recruit thousands of volunteers to participate in clinical trials being conducted at Yale’s Schools of Medicine, Nursing, and Public Health. Posters, brochures, newspaper ads, radio spots, transit ads, and community health fairs will encourage members of the Greater New Haven community, including students, to enroll in the hundreds of trials that are initiated every year.
YCCI's Fall 2011 Newsletter is Here
The Fall 2011 edition of the YCCI newsletter is out. Inside you will find information about our CTSA renewal, recruitment efforts, new informatics infrastructure and biostatistics center, as well as registering on clinicaltrials.gov, events and more.
Leadership Change for YCCI’s Community Engagement Program
Margaret Grey, DrPH, RN, FAAN, Dean of the Yale School of Nursing, has been named Director, T3 translational research core for YCCI, effective October 1, 2011.
New Community Research Services for YCCI Investigators
In order to develop new treatments that will benefit patients in the New Haven community and beyond, it is vital that the diversity of the patient population is reflected in those that participate in research studies.
Managing Clinical Trials Just Got Easier
OnCore, a Clinical Trials Management System (CTMS) that will facilitate a new level of sophistication and support for clinical and translational research, is up and running.
YCCI Partners with the Children’s Fund of Connecticut
YCCI has partnered with the Children’s Fund of Connecticut (CFC), a statewide public charitable foundation affiliated with Yale, the University of Connecticut and the CT Children’s Medical Center, to jointly fund the 2011 Child Health...
Heart Attack Patients Winning the Race to Angioplasty Treatment
Almost all heart attack patients who need the emergency artery-opening procedure known as angioplasty are receiving it within 90 minutes of being admitted to the hospital, a marked improvement from five years ago when most patients waited longer for the life-saving procedure, according to a report by Yale School of Medicine researchers and their colleagues.
Mimicking Calorie Restriction to Fight Obesity and Type 2 Diabetes
A Yale University-led research team has discovered how reduced expression of a particular gene protects against obesity and type 2 diabetes, possibly prolonging lifespan by mimicking the effects of calorie restriction. The study appears in the August 3 issue of Cell Metabolism.
Anti-Psychotic Drug Little Help to Vets With Chronic PTSD
An anti-psychotic drug commonly prescribed to patients with hard-to-treat post-traumatic stress disorder does not ease PTSD symptoms, according to a new study by the Department of Veterans Affairs and Yale School of Medicine.
2011 Awardees Join the Ranks of YCCI Scholars
The latest round of YCCI Junior Faculty Scholars has been selected, adding 11 promising Yale investigators to the ranks of one of YCCI’s most successful programs under the Clinical and Translational Science Award.
Dr. Robert Sherwin is lauded for diabetes research
Internationally renowned diabetes researcher and clinician Dr. Robert Sherwin is the recipient of the American Diabetes Association's (ADA) 2011 Albert Renold Award.
Sherwin, who has been in the forefront of diabetes research for his entire career, is the C.N.H. Long Professor of Medicine and chief of the Section of Endocrinology at Yale School of Medicine, and director of the Yale Center for Clinical Investigation and the Diabetes Endocrinology Research Center at Yale.
